On September 18, 2024, it was reported that Novo was agreeing to pay NanoVation Therapeutics up to $600 million, plus research funding in addition to tiered royalties to collaborate on up to seven ...
End of Period Subscribers of 3.7 millionRevenues of $192.9 millionGross margin of 67.1%; adjusted gross margin of 69.1%Operating Loss of $39.0 million; adjusted operating income of $35.7 million NEW ...
While expected and seen as largely incremental, Jefferies analyst Peter Welford in a Tuesday note to investors said the detailed data for three early-stage assets support moving them into Phase IIb ...
Axios Visuals Budget pressures have kept all but 13 states from covering GLP-1 drugs for weight loss through their Medicaid programs, a new report from KFF shows. Why it matters: The restrictive ...
8 Rebels fell 29-26 to No. 10 LSU in overtime in the Magnolia Bowl in Baton Rouge, handing a team with playoff expectations before the season its second loss through seven weeks. Tigers ...